Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HIT Workgroup Looking At Medication-Related Quality Measures

This article was originally published in The Pink Sheet Daily

Executive Summary

Criteria for meaningful use of health information technology could include appropriate use of brand versus generic products, appropriate use of cardioprotective drugs in patients at risk for heart attack and stroke, and tracking adverse events.

You may also be interested in...



Pharmacy-Related Waste Exceeded $403 Billion In 2010 – Express Scripts

Pharmacy benefits manager Express Scripts reported that in 2010, $403 billion in pharmacy-related waste could have been avoided across three areas – the sales channel, generic utilization and nonadherence to medications.

Pharmacy-Related Waste Exceeded $403 Billion In 2010 – Express Scripts

Pharmacy benefits manager Express Scripts reported that in 2010, $403 billion in pharmacy-related waste could have been avoided across three areas – the sales channel, generic utilization and nonadherence to medications.

PCORI Board Eyes Connection Between Health IT Meaningful Use And Comparative Effectiveness Research

Members at the Patient-Centered Outcomes Research Institute's inaugural meeting agree they should bring in HHS health IT office head to discuss intersection between electronic health records and CER.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel